RESULTS
Depression, Extrapyramidal Symptoms
SYNDROME, POSITIVE
According to the inclusion and exclusion criteria, 116 patients were assessed for their eligibility. Eighty outpatients were randomized to receive either pentoxifylline or placebo (Flow chart of the study participantsParticipants' demographics and baseline characteristics
Abbreviations: BMI, body mass index; CRP, C‐Reactive Protein; ESRS, Extrapyramidal Symptoms Rating Scale; HDRS, Hamilton Depression Rating Scale score; PANSS, Positive and negative syndrome scale score.